Dorton Katina has filed 5 insider transactions across 3 companies since June 2024.
Most recent transaction: a grant/award of 76000 shares of Prelude Therapeutics Inc ($PRLD) on October 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 17, 2025 | Prelude Therapeutics Inc | $PRLD | Dorton Katina | Not found | A | Director Stock Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 76,132,337 | 9999.99% | 0.10% |
| June 30, 2025 | TScan Therapeutics, Inc. | $TCRX | Dorton Katina | Not found | A | Stock Option (Right to Buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 26, 2025 | Fulcrum Therapeutics, Inc. | $FULC | Dorton Katina | Not found | A | Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 61,984 | 9999.99% | 58.08% |
| June 17, 2024 | Fulcrum Therapeutics, Inc. | $FULC | Dorton Katina | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 61,310 | 9999.99% | 48.93% |
| June 12, 2024 | TScan Therapeutics, Inc. | $TCRX | Dorton Katina | Not found | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |